Skip to content
The Policy VaultThe Policy Vault

Nuedexta — United Healthcare

pseudobulbar affect

Initial criteria

  • Diagnosis of pseudobulbar affect

Reauthorization criteria

  • Documentation of positive clinical response to therapy

Approval duration

12 months